Zhenling Luo

592 citations
12 papers · 500 indexed · h-index 10
Topics
Angiogenesis and VEGF in Cancer (4 papers)Histone Deacetylase Inhibitors Research (3 papers)Pluripotent Stem Cells Research (2 papers)
Journals
Journal of Biological ChemistrySHILAP Revista de lepidopterologíaThe Plant Journal

In The Last Decade

Zhenling Luo

11 papers receiving 495 citations

Peers

Zhenling Luo
Comparison fields: 5 of 66
  • Molecular Biology 329
  • Cancer Research 124
  • Surgery 74
  • Physiology 66
  • Immunology 59
Replace Andriani Margariti with:
Andriani Margariti United Kingdom
Sekyung Oh South Korea
Cuilan Yang China
Lin Qiu China
Patrick L. Leslie United States
Hea Nam Hong South Korea
Miaomei Yu China
Pei Liang China
Agne Frismantiene Switzerland
Philip Coryell United States
Zhenling Luo relative to Andriani Margariti United Kingdom Andriani Margariti's profile →
Citations per field
00.5×3.7×
Andriani Margariti · 1×
Citations per year

Countries citing papers authored by Zhenling Luo

Since Specialization
Citations

This map shows the geographic impact of Zhenling Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenling Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenling Luo more than expected).

Fields of papers citing papers by Zhenling Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenling Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenling Luo. The network helps show where Zhenling Luo may publish in the future.

Co-authorship network of co-authors of Zhenling Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenling Luo. A scholar is included among the top collaborators of Zhenling Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenling Luo. Zhenling Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 0
2 9
3 32
4 53
5 48
6 33
7 27
8 73
9 36
10 25
11 6
12 158

About Zhenling Luo

Zhenling Luo is a scholar working on Cancer Research, Molecular Biology and Cell Biology, having authored 12 papers that have together received 500 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Pluripotent Stem Cells Research (2 papers). The work is most often cited by research in Cancer Research (124 citations), Genetics (55 citations) and Molecular Biology (329 citations). Zhenling Luo has collaborated with scholars based in United Kingdom, China and Brazil. Frequent co-authors include Qingzhong Xiao, Qingbo Xu, Lingfang Zeng, Anna Pepe, Andriani Margariti, Shu Ye, Andrew H. Baker, Nicole M. Kane, Costanza Emanueli and Gang Wang. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Plant Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026